Chromenes: Potential New Chemotherapeutic Agents for Cancer
Future Medicinal Chemistry2013Vol. 5(14), pp. 1647–1660
Citations Over TimeTop 10% of 2013 papers
Abstract
Cancer is a major devastating disease, and is a leading cause of death worldwide. Despite the progress in cancer treatment, cancer mortality rate remains high. Therefore, the discovery and development of improved anticancer drugs to treat cancer are needed. 4H-chromenes have strong cytotoxicity against a panel of human cancer cell lines involving pathways that include microtubule depolarization and tumor vasculature disruption. A chromene analog, Crolibulin™ (EPC2407) is currently in Phase I/II clinical trials for the treatment of advanced solid tumors. This article reviews the general synthesis, biological activities and structure-activity relatinships of different classes of chromenes.
Related Papers
- → Amyloid β cytotoxicity is enhanced or reduced depending on formation of amyloid β oligomeric forms(2020)8 cited
- Cytotoxicity test of medical device with silver nanoparticles(2010)
- → Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon(1980)77 cited
- Protective effect of Cynomorii Herba extract on $H_2O_2$-induced cytotoxicity(2004)
- Synthesis and antitumor activity of aza-chalcones and their Pt(IV) complexes(2011)